CA2751660C - Un appareil de differentiation de particule pour les spermatozoides - Google Patents

Un appareil de differentiation de particule pour les spermatozoides Download PDF

Info

Publication number: CA2751660C
Authority: CA; Canada
Prior art keywords: per; sperm; sperm cells; spermatozoa; particle differentiation
Prior art date: 2000-05-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA2751660A

Other languages

English (en)

Other versions

CA2751660A1 (fr

Inventor

Kenneth M. Evans

Munster Erik B. Van

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

XY LLC

Original Assignee

XY LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-09

Filing date

2001-05-09

Publication date

2013-08-20

2001-05-09 Application filed by XY LLC filed Critical XY LLC

2001-05-09 Priority to CA2803774A priority Critical patent/CA2803774C/fr

2001-05-09 Priority claimed from CA2408939A external-priority patent/CA2408939C/fr

2001-11-15 Publication of CA2751660A1 publication Critical patent/CA2751660A1/fr

2013-08-20 Application granted granted Critical

2013-08-20 Publication of CA2751660C publication Critical patent/CA2751660C/fr

2021-05-09 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000002245 particle Substances 0.000 title claims description 86
230000004069 differentiation Effects 0.000 title claims description 37
210000004027 cell Anatomy 0.000 claims description 142
210000002593 Y chromosome Anatomy 0.000 claims description 83
210000001766 X chromosome Anatomy 0.000 claims description 82
238000000926 separation method Methods 0.000 claims description 61
239000012530 fluid Substances 0.000 claims description 55
241000283690 Bos taurus Species 0.000 claims description 46
241000283073 Equus caballus Species 0.000 claims description 35
239000000463 material Substances 0.000 claims description 18
241000124008 Mammalia Species 0.000 claims description 13
108091093105 Nuclear DNA Proteins 0.000 claims description 12
230000004044 response Effects 0.000 claims description 4
230000015572 biosynthetic process Effects 0.000 claims description 3
238000005516 engineering process Methods 0.000 abstract description 25
238000007493 shaping process Methods 0.000 abstract description 12
238000004458 analytical method Methods 0.000 abstract description 8
230000009027 insemination Effects 0.000 description 65
238000000034 method Methods 0.000 description 40
230000005284 excitation Effects 0.000 description 30
108020004414 DNA Proteins 0.000 description 28
230000016087 ovulation Effects 0.000 description 27
241001465754 Metazoa Species 0.000 description 25
230000000694 effects Effects 0.000 description 25
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 21
210000004940 nucleus Anatomy 0.000 description 19
230000004907 flux Effects 0.000 description 18
230000003287 optical effect Effects 0.000 description 18
210000000582 semen Anatomy 0.000 description 17
238000000684 flow cytometry Methods 0.000 description 16
238000000338 in vitro Methods 0.000 description 16
230000035558 fertility Effects 0.000 description 14
230000004720 fertilization Effects 0.000 description 14
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 12
230000003321 amplification Effects 0.000 description 11
238000003199 nucleic acid amplification method Methods 0.000 description 11
230000005670 electromagnetic radiation Effects 0.000 description 10
238000002347 injection Methods 0.000 description 10
239000007924 injection Substances 0.000 description 10
241000894007 species Species 0.000 description 10
244000309464 bull Species 0.000 description 9
210000000349 chromosome Anatomy 0.000 description 9
244000309465 heifer Species 0.000 description 9
210000001161 mammalian embryo Anatomy 0.000 description 9
230000004048 modification Effects 0.000 description 9
238000012986 modification Methods 0.000 description 9
230000010287 polarization Effects 0.000 description 9
230000001850 reproductive effect Effects 0.000 description 9
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 8
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 8
241000282898 Sus scrofa Species 0.000 description 8
235000013365 dairy product Nutrition 0.000 description 8
210000002257 embryonic structure Anatomy 0.000 description 8
229940035638 gonadotropin-releasing hormone Drugs 0.000 description 8
230000035935 pregnancy Effects 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 7
238000011161 development Methods 0.000 description 7
230000018109 developmental process Effects 0.000 description 7
230000012173 estrus Effects 0.000 description 7
230000006698 induction Effects 0.000 description 7
238000005259 measurement Methods 0.000 description 7
PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 6
241001494479 Pecora Species 0.000 description 6
206010042573 Superovulation Diseases 0.000 description 6
230000009471 action Effects 0.000 description 6
235000015278 beef Nutrition 0.000 description 6
238000004163 cytometry Methods 0.000 description 6
238000001514 detection method Methods 0.000 description 6
230000006870 function Effects 0.000 description 6
238000004321 preservation Methods 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
241000283707 Capra Species 0.000 description 5
108010062540 Chorionic Gonadotropin Proteins 0.000 description 5
102000011022 Chorionic Gonadotropin Human genes 0.000 description 5
229920005439 Perspex® Polymers 0.000 description 5
230000008901 benefit Effects 0.000 description 5
244000309466 calf Species 0.000 description 5
108700025485 deslorelin Proteins 0.000 description 5
238000005538 encapsulation Methods 0.000 description 5
229940084986 human chorionic gonadotropin Drugs 0.000 description 5
239000007788 liquid Substances 0.000 description 5
210000000287 oocyte Anatomy 0.000 description 5
239000004926 polymethyl methacrylate Substances 0.000 description 5
238000012552 review Methods 0.000 description 5
241000252095 Congridae Species 0.000 description 4
239000004606 Fillers/Extenders Substances 0.000 description 4
102000006771 Gonadotropins Human genes 0.000 description 4
108010086677 Gonadotropins Proteins 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
230000001351 cycling effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
239000003814 drug Substances 0.000 description 4
239000002622 gonadotropin Substances 0.000 description 4
238000011160 research Methods 0.000 description 4
230000007017 scission Effects 0.000 description 4
238000010186 staining Methods 0.000 description 4
239000000126 substance Substances 0.000 description 4
239000012780 transparent material Substances 0.000 description 4
GJKXGJCSJWBJEZ-XRSSZCMZSA-N Deslorelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CNC2=CC=CC=C12 GJKXGJCSJWBJEZ-XRSSZCMZSA-N 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
239000011324 bead Substances 0.000 description 3
210000002459 blastocyst Anatomy 0.000 description 3
238000009395 breeding Methods 0.000 description 3
230000001488 breeding effect Effects 0.000 description 3
239000002775 capsule Substances 0.000 description 3
230000008859 change Effects 0.000 description 3
238000005138 cryopreservation Methods 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
229960005408 deslorelin Drugs 0.000 description 3
238000009826 distribution Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
239000005556 hormone Substances 0.000 description 3
239000007943 implant Substances 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
238000000386 microscopy Methods 0.000 description 3
210000003739 neck Anatomy 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
210000004681 ovum Anatomy 0.000 description 3
230000001817 pituitary effect Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
239000000047 product Substances 0.000 description 3
230000005855 radiation Effects 0.000 description 3
230000035899 viability Effects 0.000 description 3
241000282817 Bovidae Species 0.000 description 2
241000282832 Camelidae Species 0.000 description 2
PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
206010062767 Hypophysitis Diseases 0.000 description 2
238000003744 In vitro fertilisation Methods 0.000 description 2
241000282339 Mustela Species 0.000 description 2
241000289565 Notamacropus eugenii Species 0.000 description 2
241000282376 Panthera tigris Species 0.000 description 2
241000283080 Proboscidea <mammal> Species 0.000 description 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
230000006399 behavior Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000007789 gas Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
230000035479 physiological effects, processes and functions Effects 0.000 description 2
210000003635 pituitary gland Anatomy 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000002604 ultrasonography Methods 0.000 description 2
KPSXIMVWBWSQEG-ITQXDASVSA-N (2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-[(2s)-2-[[2-(ethylamino)-2-oxoethyl]carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]ami Chemical compound CCNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CNC2=CC=CC=C12 KPSXIMVWBWSQEG-ITQXDASVSA-N 0.000 description 1
PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
KFUDFIMHDRJVLV-MSKGSUGCSA-N (z)-7-[(1s,2r,3r,5s)-2-[(2s)-3-(3-chlorophenoxy)-2-hydroxypropyl]sulfanyl-3,5-dihydroxycyclopentyl]hept-5-enoic acid Chemical compound C([C@H](O)CS[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(Cl)=C1 KFUDFIMHDRJVLV-MSKGSUGCSA-N 0.000 description 1
101710177204 Atrochrysone carboxyl ACP thioesterase Proteins 0.000 description 1
241000120506 Bluetongue virus Species 0.000 description 1
241000283725 Bos Species 0.000 description 1
108010037003 Buserelin Proteins 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000219321 Caryophyllaceae Species 0.000 description 1
241000283153 Cetacea Species 0.000 description 1
239000004099 Chlortetracycline Substances 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
235000002845 Dianthus plumarius Nutrition 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000283086 Equidae Species 0.000 description 1
108010011631 Equine Gonadotropins Proteins 0.000 description 1
241000283070 Equus zebra Species 0.000 description 1
208000022555 Genital disease Diseases 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
235000019687 Lamb Nutrition 0.000 description 1
208000035752 Live birth Diseases 0.000 description 1
241000880309 Neofelis nebulosa Species 0.000 description 1
241000283903 Ovis aries Species 0.000 description 1
241000289676 Phalangeridae Species 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
241000282887 Suidae Species 0.000 description 1
241000289672 Trichosurus vulpecula Species 0.000 description 1
206010047486 Virilism Diseases 0.000 description 1
208000019291 X-linked disease Diseases 0.000 description 1
LYCYLGFSIXIXAB-NUZRHMIVSA-N acetic acid;(2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-[(2s)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-h Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CNC2=CC=CC=C12 LYCYLGFSIXIXAB-NUZRHMIVSA-N 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
238000003975 animal breeding Methods 0.000 description 1
230000002513 anti-ovulatory effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 1
229960002719 buserelin Drugs 0.000 description 1
210000000085 cashmere Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
229960004475 chlortetracycline Drugs 0.000 description 1
235000019365 chlortetracycline Nutrition 0.000 description 1
229960004407 chorionic gonadotrophin Drugs 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
239000004020 conductor Substances 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
238000012864 cross contamination Methods 0.000 description 1
238000011461 current therapy Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
229960004165 deslorelin acetate Drugs 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000012631 diagnostic technique Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
238000001152 differential interference contrast microscopy Methods 0.000 description 1
229960001342 dinoprost Drugs 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
230000001158 estrous effect Effects 0.000 description 1
210000005002 female reproductive tract Anatomy 0.000 description 1
230000008175 fetal development Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
238000001825 field-flow fractionation Methods 0.000 description 1
244000144992 flock Species 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
230000008217 follicular development Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
229940094892 gonadotropins Drugs 0.000 description 1
230000036541 health Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
244000144980 herd Species 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
238000005286 illumination Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000001788 irregular Effects 0.000 description 1
238000002357 laparoscopic surgery Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000004811 liquid chromatography Methods 0.000 description 1
244000144972 livestock Species 0.000 description 1
229950002158 luprostiol Drugs 0.000 description 1
230000000938 luteal effect Effects 0.000 description 1
238000003754 machining Methods 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
230000035800 maturation Effects 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000027758 ovulation cycle Effects 0.000 description 1
230000000624 ovulatory effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000010363 phase shift Effects 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000186 progesterone Substances 0.000 description 1
229960003387 progesterone Drugs 0.000 description 1
PXGPLTODNUVGFL-YNNPMVKQSA-N prostaglandin F2alpha Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-YNNPMVKQSA-N 0.000 description 1
230000000541 pulsatile effect Effects 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000011084 recovery Methods 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000000979 retarding effect Effects 0.000 description 1
102200016458 rs104894274 Human genes 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000001932 seasonal effect Effects 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000009329 sexual behaviour Effects 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
230000008010 sperm capacitation Effects 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
210000003905 vulva Anatomy 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA2751660A 2000-05-09 2001-05-09 Un appareil de differentiation de particule pour les spermatozoides Expired - Lifetime CA2751660C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2803774A CA2803774C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US20308900P	2000-05-09	2000-05-09
US60/203,089		2000-05-09
US23975200P	2000-10-12	2000-10-12
US60/239,752		2000-10-12
US26757101P	2001-02-10	2001-02-10
US60/267,571		2001-02-10
CA2408939A CA2408939C (fr)	2000-05-09	2001-05-09	Populations de spermatozoides tres purs, porteurs de chromosomes x et y

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2408939A Division CA2408939C (fr)	2000-05-09	2001-05-09	Populations de spermatozoides tres purs, porteurs de chromosomes x et y

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2803774A Division CA2803774C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides

Publications (2)

Publication Number	Publication Date
CA2751660A1 CA2751660A1 (fr)	2001-11-15
CA2751660C true CA2751660C (fr)	2013-08-20

Family

ID=44789655

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CA2858892A Expired - Lifetime CA2858892C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides
CA2751660A Expired - Lifetime CA2751660C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides
CA2803774A Expired - Lifetime CA2803774C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA2858892A Expired - Lifetime CA2858892C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA2803774A Expired - Lifetime CA2803774C (fr)	2000-05-09	2001-05-09	Un appareil de differentiation de particule pour les spermatozoides

Country Status (1)

Country	Link
CA (3)	CA2858892C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2930062T3 (es) *	2003-03-28	2022-12-05	Inguran Llc	Aparato para detectar el punto de rotura de un sistema de generación de gotitas

2001
- 2001-05-09 CA CA2858892A patent/CA2858892C/fr not_active Expired - Lifetime
- 2001-05-09 CA CA2751660A patent/CA2751660C/fr not_active Expired - Lifetime
- 2001-05-09 CA CA2803774A patent/CA2803774C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2858892C (fr)	2019-06-11
CA2803774C (fr)	2014-09-30
CA2751660A1 (fr)	2001-11-15
CA2858892A1 (fr)	2001-11-15
CA2803774A1 (fr)	2001-11-15

Publication	Publication Date	Title
CA2408939C (fr)	2011-11-08	Populations de spermatozoides tres purs, porteurs de chromosomes x et y
AU2001263039A1 (en)	2002-02-07	High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
US20040049801A1 (en)	2004-03-11	System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
WO2002043574A9 (fr)	2003-12-18	Systeme de dissociation de spermatozoides congeles-decongeles porteurs d'un chromosome x de ceux porteurs d'un chromosome y
CA2751660C (fr)	2013-08-20	Un appareil de differentiation de particule pour les spermatozoides
AU2011265548B2 (en)	2012-12-20	High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
CA2887757A1 (fr)	2002-06-06	Systeme permettant de realiser une fecondation in vitro avec des spermatozoides separes en population porteuse de chromosome x et en population porteuse de chromosome y

Legal Events

Date	Code	Title	Description
2011-09-01	EEER	Examination request
2021-07-12	MKEX	Expiry	Effective date: 20210510